Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group.
about
Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition timesThe effect of Tai Chi exercise on gait initiation and gait performance in persons with Parkinson's disease.Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience.Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.Validation of an ambulatory capacity measure in Parkinson disease: a construct derived from the Unified Parkinson's Disease Rating Scale.Two-Year Trajectory of Fall Risk in People With Parkinson Disease: A Latent Class Analysis.Long-duration Parkinson's disease: role of lateralization of motor featuresPredictors of time to initiation of symptomatic therapy in early Parkinson's disease.Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson diseasePredictors of cognitive decline in the early stages of Parkinson's disease: a brief cognitive assessment longitudinal study.Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.Rasagiline and rapid symptomatic motor effect in Parkinson's disease: review of literature.Variability of Anticipatory Postural Adjustments During Gait Initiation in Individuals With Parkinson Disease.Predictors of Functional Decline in Early Parkinson's Disease: NET-PD LS1 Cohort.Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease.Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.A longitudinal study of parkinsonism and disability in a community population of older people.Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9-year follow-up study.
P2860
Q28275419-1BD11372-87EB-4891-A073-CC460B3309E8Q30427284-7DB2E0CB-C556-4832-814B-B8F26F39B64EQ33731897-DC329B27-DE33-41EE-8359-657C77562EEDQ34301396-F48DEABC-360F-46E5-9425-D970762F0A85Q35772039-DCD4E2A2-3CD0-4C01-B7D3-DF4F06286D4DQ36626889-0DAC1E1A-52DF-42D6-9D96-AFE5095A967EQ36793671-2A94A69F-5AC6-4DEC-BC81-97C3DCC79EA2Q37062111-6C2F655B-0139-49DF-B534-61E97D4EA9A3Q37228718-73BFF98F-AB2E-41D9-A2F1-C94116764BFCQ37329479-1B5C996A-D4D1-40CF-A7FE-659F682A4C1AQ38428967-E0150665-AB09-4958-BD6D-5AB1E6E110D2Q38497529-B5B397A2-1D71-41C5-B346-21DEE320EEC5Q38936151-E1B135C4-9945-49B8-9BBB-0BD7316BC2F2Q40240247-445E5B46-F2A0-4808-8DA5-3B1F448C8E71Q41517891-75D87964-10FE-4F70-B84A-7C7A9A0D66E3Q44125040-B8076890-955D-4565-B822-438D9F0B4497Q50282977-3F92B8FF-8F9A-4021-9326-29293D6862E3Q50640051-FA4773E3-EC92-485D-BBCF-7D70FF4F4E29
P2860
Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Factors predictive of the need ...... se. The Parkinson Study Group.
@en
Factors predictive of the need ...... se. The Parkinson Study Group.
@nl
type
label
Factors predictive of the need ...... se. The Parkinson Study Group.
@en
Factors predictive of the need ...... se. The Parkinson Study Group.
@nl
prefLabel
Factors predictive of the need ...... se. The Parkinson Study Group.
@en
Factors predictive of the need ...... se. The Parkinson Study Group.
@nl
P2093
P1433
P1476
Factors predictive of the need ...... se. The Parkinson Study Group.
@en
P2093
J Jankovic
M P McDermott
S Gauthier
P304
P356
10.1001/ARCHNEUR.1995.00540300037010
P577
1995-06-01T00:00:00Z